Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
AZ’8037
i
Other names:
AZ’8037, COmpound 25
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
AstraZeneca
Drug class:
KRAS inhibitor
Related drugs:
‹
MRTX1257 (4)
AZD4785 (1)
JAB-3312 (1)
QTX3034 (1)
ATG-012 (0)
ELI-002 7P (0)
JNJ-74699157 (0)
LY3499446 (0)
SLATE-KRAS (0)
Undisclosed KRAS peptide vaccine (0)
Undisclosed KRAS-loder (0)
Undisclosed MSC-derived Exosomes with KrasG12D siRNA (0)
Undisclosed anti-KRAS G12D mTCR PBL (0)
Undisclosed mDC3/8-KRAS vaccine (0)
mRNA-5671 (0)
MRTX1257 (4)
AZD4785 (1)
JAB-3312 (1)
QTX3034 (1)
ATG-012 (0)
ELI-002 7P (0)
JNJ-74699157 (0)
LY3499446 (0)
SLATE-KRAS (0)
Undisclosed KRAS peptide vaccine (0)
Undisclosed KRAS-loder (0)
Undisclosed MSC-derived Exosomes with KrasG12D siRNA (0)
Undisclosed anti-KRAS G12D mTCR PBL (0)
Undisclosed mDC3/8-KRAS vaccine (0)
mRNA-5671 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
KRAS G12C + KRAS G12V
Non Small Cell Lung Cancer
KRAS G12C + KRAS G12V
Non Small Cell Lung Cancer
AZ’8037
Resistant: D – Preclinical
AZ’8037
Resistant
:
D
AZ’8037
Resistant: D – Preclinical
AZ’8037
Resistant
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login